Sleep Tech Devices Market revenue to reach USD 50 Billion by 2035, says Research Nester
August 10, 2023 07:00 ET
|
Research Nester
New York, Aug. 10, 2023 (GLOBE NEWSWIRE) -- The global sleep tech devices market size is slated to expand at ~15% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 50...
APNIMED to Participate in the 43rd Annual Canaccord Genuity Global Growth Conference
August 01, 2023 08:00 ET
|
Apnimed, Inc.
CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep...
Apnimed to Participate in the William Blair Virtual Conference: Transitioning Biotech Breakthroughs to Commercial Success
July 12, 2023 08:00 ET
|
Apnimed, Inc.
CAMBRIDGE, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep...
ProSomnus Announces Second Quarter 2023 Investor Call and Business Update
July 06, 2023 08:29 ET
|
ProSomnus Sleep Technologies, Inc.
PLEASANTON, Calif., July 06, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea (“OSA”), will report its strong second...
Ambulatory Polysomnography (PSG) Systems Market to Garner $570.7 Million by 2031 with 6.0% CAGR | Research Dive
June 14, 2023 09:00 ET
|
Research Dive
New York, USA, June 14, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global ambulatory polysomnography (PSG) systems market is projected to generate a revenue of...
Apnimed to Participate in the 2023 BIO International Convention
May 23, 2023 07:00 ET
|
Apnimed, Inc.
CAMBRIDGE, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep apnea...
Apnimed Presented Positive Phase 2b Results on AD109, an Investigational Oral Drug for Obstructive Sleep Apnea, for the First Time at ATS 2023
May 21, 2023 10:00 ET
|
Apnimed, Inc.
-- New MARIPOSA Study Data Showed AD109 Statistically Significantly Improved Both Objective and Subjective Outcomes in OSA Patients -- MARIPOSA Results Support Advancing AD109 to Phase 3 CAMBRIDGE,...
RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
November 17, 2022 08:45 ET
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Nov. 17, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Pink Market:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
North America Sleep Tech Devices Market size to exceed $17 Bn by 2027, says Graphical Research
September 13, 2022 08:00 ET
|
Graphical Research
Pune, India, Sept. 13, 2022 (GLOBE NEWSWIRE) -- As per a recent industry report put forward by Graphical Research, the North America sleep tech devices market is forecast to register its name in...
Sleep Tech Devices Market to cross USD 67 billion by 2030, says Global Market Insights Inc.
May 25, 2022 03:17 ET
|
Global Market Insights Inc.
Selbyville, Delaware, May 25, 2022 (GLOBE NEWSWIRE) -- The sleep tech devices market value is expected to reach USD 67 billion by 2030, according to a new research report by Global Market Insights...